A two-year experience with a rapid access, self-sealing, polycarbonate urethane nanofiber vascular access graft for hemodialysis.

Objective: Evaluating the safety and efficacy of the AVflo™ graft in terms of patency and complications (early and late) over 2 years.

Materials And Methods: Twelve end-stage renal disease (ESRD) patients (age: mean 68.5 ± 10 years) were followed up for a mean period of 946 ± 570 days after receiving an implantation of the graft for HD.

Early experience with a newly developed electrospun polycarbonate-urethane vascular graft for hemodialysis access.

Purpose: In this pilot study, we tested a newly developed electrospun multilayered, self-sealing graft, AVflo™, specifically designed for early hemodialysis access. 


Methods: Ten eligible consenting patients had a polycarbonate-urethane graft (AVflo™) implanted and were followed up prospectively for at least six months. Performance measures included graft patency, complications and time to first cannulation.

Search for genomic sequences of microbial agents in atherosclerotic plaques.

Atherosclerosis is a complex, multifactorial disease. Several studies have reported a possible association between infection with microbial agents and atherogenesis. Chlamydia pneumoniae (C.

[Suprarenal aortic cross-clamping and renal function].

Renal failure occurs in 1-13% of abdominal aortic reconstructions. In our survey of 81 abdominal aortic aneurysms, out of 100 abdominal aortic operations, suprarenal cross-clamping was necessary in 4 cases, with 1 transient postoperative dialysis, followed by a fully restored renal function in 19th postoperative day. Among the cases with infrarenal aortic cross-clamping, one patient died owing to colonic infarction, another patient presented progressive and persistent renal damage.

Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male.

We describe an unusual case of bilateral breast cancer synchronous with pituitary macroprolactinoma in a young male. Up to date, only very few of such cases have been described worldwide and to our knowledge this is the first one in which both breast cancer and pituitary macroadenoma have been found together at the time of presentation. A 45-year-old male was diagnosed as having a pituitary macroprolactinoma and bilateral breast cancer on the basis of hypogonadism (testosterone 2.